Publications
Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
Janardana R, Amin SN, Rajasekhar L, Pinto B, Kodishala C, Selvam S, Shobha V This study evaluates the effectiveness of low-dose rituximab in patients with refractory idiopathic inflammatory myopathies, demonstrating its clinical benefits and therapeutic potential.
